. Author manuscript; available in PMC: 2016 Nov 1.

Published in final edited form as: J Heart Lung Transplant. 2015 Jun 11;34(11):1436–1441. doi: 10.1016/j.healun.2015.05.020

Table 4.

Multivariable Adjusted Cox Proportional Hazard Regression Analysis

Covariates	Relative Adjusted Hazard for Death^a
	90 days		1 Year^b		2 Years		5 Years
	HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	P
LAS≥50	1.98 (1.27, 3.12)	0.003	1.41 (1.00, 2.01)	0.05	1.38 (1.04, 1.83)	0.03	1.26 (0.99, 1.60)	0.07
Age	1.01 (0.99, 1.04)	0.27	1.00 (0.98, 1.01)	0.58	0.98 (0.96, 0.99)	0.002	0.97 (0.96, 0.98)	>0.001
Gender (% F)	0.86 (0.56, 1.34)	0.51	0.89 (0.61, 1.29)	0.58	1.13 (0.88, 1.46)	0.34	1.07 (0.87, 1.33)	0.48
Ischemic time	1.17 (1.03, 1.33)	0.02	1.10 (0.99, 1.24)	0.18	1.04 (0.96, 1.13)	0.30	0.99 (0.93, 1.06)	0.80
Donor CMV+	1.48 (0.91, 2.40)	0.11	1.62 (1.07, 2.46)	0.14	1.22 (0.93, 1.59)	0.15	1.15 (0.92, 1.43)	0.21
N-P Insurance	1.40 (0.91, 2.16)	0.13	1.49 (1.02, 2.17)	0.03	1.29 (1.00, 1.66)	0.05	1.34 (1.09, 1.66)	0.01

HR = hazard ratio; CI = confidence interval; CMV+ = positive CMV antibody; N-P = non-private, LAS = lung allocation score

Adjusted for all covariates listed in the table.

Primary Outcome